Pioneer of weight‑loss injections who switched from pills — and discovered what motivates you to seek treatment

Only a few percent of those suffering from obesity today take medications like Ozempic, and at Novo Nordisk they wonder if fear of the needle is part of the reason. Emil L'Arsen, the company's deputy CEO, says in an interview with ynet about the triple dose of Wegovy, which brings an average weight loss of about 21%, and about what the company has learned about its patients: “We learned that talking about the long‑term benefits is not what really motivates them. They love to lose weight.”

translateRead translated

Automatic translation by Google

Curated from Ynet Health. Classified as Health by AI, which sometimes makes mistakes.

More like this

More ›

Upworthy10/16/2026

Researchers discover the age at which most people find their true selves

It's a decades-long process. The post Researchers discover the age at which most people find their true selves appeared first on Upworthy.

Scary Mommy10/16/2026

9 Things To Do Now So The Holidays Aren’t Such A Cluster, Mentally

Scary Mommy asked Kati Morton, LMFT, what we can do starting now to make the holidays easier on ourselves emotionally and mentally.

LitHub10/16/2026

Here’s what’s making us happy this week.

If we had a catchphrase at Lit Hub this week, it could be the bard’s whole bit on music and the food of love. Your favorite masthead has been eating, cooking, baking, nesting, and jamming. Jonny Diamond reports from the